Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-02-13 @ 12:29 PM
Study NCT ID:
NCT03692767
Status:
UNKNOWN
Last Update Posted:
2019-01-30
First Post:
2018-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
Sponsor:
Allife Medical Science and Technology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-11
Completion Date Type:
ESTIMATED
First Submit Date:
2018-09-28
First Submit QC Date:
None
Study First Post Date:
2018-10-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-29
Last Update Post Date:
2019-01-30
Last Update Post Date Type:
ACTUAL